CCR-11

CAS No. 301687-87-6

CCR-11( —— )

Catalog No. M34059 CAS No. 301687-87-6

CCR-11 is a tannin-containing derivative with antimicrobial activity. CCR-11 inhibits the proliferation of B. subtilis and HeLa cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 192 Get Quote
5MG 297 Get Quote
10MG 443 Get Quote
25MG 692 Get Quote
50MG 908 Get Quote
100MG 1242 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CCR-11
  • Note
    Research use only, not for human use.
  • Brief Description
    CCR-11 is a tannin-containing derivative with antimicrobial activity. CCR-11 inhibits the proliferation of B. subtilis and HeLa cells.
  • Description
    (E/Z)-CCR-11 (Comp 12) is a selective CD38 inhibitor, with an IC50 of 20.8 μM against CD38 cyclase. (E/Z)-CCR-11promotes increases in cellular NAD+ levels and interferon γ.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Antibiotic
  • Recptor
    Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    301687-87-6
  • Formula Weight
    355.35
  • Molecular Formula
    C15H8F3NO2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC(F)(F)C1=CC=CC(=C1)C1=CC=C(O1)\C=C1\SC(=S)NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Thomas Z Benton, et al. Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation. RSC Adv. 2021 Oct 11;11(53):33260-33270.?
molnova catalog
related products
  • Bekanamycin

    Bekanamycin is an aminoglycoside antibiotic.

  • Isothiuronium

    Isothiuronium (AHR 1911) is a protein synthesis inhibitor with antimicrobial and anti-inflammatory activity that induces apoptosis and reduces melanoma cell invasion, and can be used in dermatitis research.

  • Cefuzonam

    Cefuzonam is a novel cephalosporin with anti-inflammatory and antibacterial activity that can be used in studies of respiratory tract infections, tonsillitis, and hepatobiliary infections.